ICU Medical (ICUI) Tops Q4 EPS by 36c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mail
Get Alerts ICUI Hot Sheet
Price: $160.84 -0.15%
Revenue Growth %: +2.8%
Financial Fact:
Net sales: 97.1M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Revenue Growth %: +2.8%
Financial Fact:
Net sales: 97.1M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $1.57, $0.36 better than the analyst estimate of $1.21. Revenue for the quarter came in at $587.86 million versus the consensus estimate of $561.9 million.
GUIDANCE:
ICU Medical sees FY2024 EPS of $4.40-$5.10, versus the consensus of $5.18.
Expects adjusted EBITDA to be in the range of $330 million to $370 million
For earnings history and earnings-related data on ICU Medical (ICUI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Rollins falls 7% on third quarter earnings and revenue miss
- Nokia (NOK) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
